European Journal of Ultrasound
NEWS

Impact Factor 2023

The Impact Factor 2023 for the UiM/EJU is 3.1

 

       UiM/EJU subscribers
       are now provided with
       a mobile digital issue
       of their journal.
       The eRef app enables
       you to comfortably

read the latest journal issues on your tablet.

Find out more about the eRef app here

Use UiM/EJU offline • optimal reading experience • scalable font size • one click to download UiM/EJU

Ultrasound International Open

New open-access journal!

For author instructions and further information about publishing in UIO, visit www.thieme.com/uio

 

EFSUMB on FACEBOOK

EFSUMB NEWS


 
How to get your paper published in a scientific journal

In general, when you write a paper to submit to scientific journals there is high competition from other authors and research groups. It can be a challenge to get your work published, especially in your early career. It is important that you can create interest of your research results by capturing editors and reviewer's interest. It can be stressful getting a paper published in a scientific journal.

>> Here are some tips so you hopefully don't get stressed during the preparation of your manuscript, submission and reviewers' comments!
 
 

 

More information on all EUROSON Schools can be found on www.efsumb.org >>

 

European Journal of Ultrasound 03-2025

Identification of differentiating sonographic features between fibroadenomas and malignant tumors of the breast mimicking fibroadenomas: 10-year experience in 421 histologically verified cases

Swoboda M, Deeg J, Egle D et. al.

Ultrasound is a highly effective imaging tool for assessing abnormalities within the breast. However, especially the identification of malignant tumors of the breast mimicking fibroadenomas (MTMF) by means of breast ultrasound can be challenging. This study aimed to identify reliable imaging characteristics of MTMF. This retrospective study was approved by the local ethics review board. After screening 623 patients, 421 cases with histologically verified fibroadenomas and MTMF between 2011 and 2021 were included. Sonographic features were compared to histopathological results and an algorithmbased quantitative ranking of predictors contributing most to the correct classification of malignant tumors was conducted.